Podcasts about msd

We have a lot of new drill results out this morning. MSD covers the latest from Cabral Gold, Q2 Metals, GreenLight Metals and Scorpio Gold today. Central Asia Metals has announced a proposed all-share acquisition of Cygnus Metals valued at approximately A$232 million. Newcore Gold has increased its 2026 drill program at the Enchi Gold Project in Ghana to 80,000 metres. Integra Resources has appointed Ausenco Engineering USA South as lead partner for detailed engineering at the DeLamar Gold-Silver Project.This episode of Mining Stock Daily is brought to you by... ⁠⁠⁠⁠⁠⁠Revival Gold ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Vizsla Silver⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Equinox Gold⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Integra Resources ⁠⁠⁠⁠⁠⁠

Tocvan Ventures' Chris Gordon joins MSD to update exploration and development work at the Gran Pilar gold-silver project in Sonora, Mexico. The company is 6,000 meters into a planned 20,000-meter drill program and has identified new mineralized zones away from the main deposit, including El Mesquite and other South Block targets. Tocvan is also advancing its pilot mine, with infrastructure underway, processing equipment expected soon, and first processing targeted for October. Gordon says upcoming catalysts include drilling, pilot production, permitting, and a maiden resource estimate.

MSD's Ian Wagner speaks with Latin Metals CEO Keith Henderson at Deutsche Gold Messe in Frankfurt. Henderson outlines the company's prospect-generator model, which prioritizes asset-level dilution over shareholder dilution by bringing in partners to fund high-risk exploration. Latin Metals is focused on Argentina and Peru, with projects spanning copper, gold and broader base-metal opportunities. Henderson highlights the company's 500,000-hectare sediment-hosted copper play in Argentina and the Organullo porphyry project, where Moxico is funding major drilling and studies. Latin Metals trades as LMS on the TSX-V and LMSQF on the OTCQB.

MSD's Ian Wagner speaks with Jonathan Egilo of Axo Metals about the company's shift from copper exploration toward near-term gold development in Mexico. Egilo details Axo's acquisition of the San Antonio gold project, a partly built heap-leach asset with a 1.1-million-ounce resource and a high-grade oxide starter pit. He also discusses the La Huerta copper project, ongoing drilling, permitting work, and the company's build-to-operate strategy as Axo looks to advance San Antonio toward production and cash flow.

This episode covers: Cardiology This Week: A concise summary of recent studies The heart in high altitude Mitral annular disjunction Mythbusters: Weekend mortality Host: Rick Grobbee Guests: JP Carpenter, Kristina Haugaa, Silvia Ulrich Want to watch that episode? Go to: https://esc365.escardio.org/event/2563 Want to watch that extended interview on mitral annular disjonction, go to: https://esc365.escardio.org/event/2563?resource=interview   Disclaimer ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina, Rick Grobbee, Kristina Haugaa, Nicolle Kraenkel and Silvia Ulrich have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada.  Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Rick Grobbee Guest: Kristina Haugaa Want to watch that extended interview on https://esc365.escardio.org/event/2563?resource=interview Go to: Want to watch that episode? Go to: https://esc365.escardio.org/event/2563   Disclaimer ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina, Rick Grobbee, Kristina Haugaa and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

MSD's Ian Wagner speaks with Kingfisher Metals President and CEO Dustin Perry at Deutsche Goldmesse in Frankfurt. Perry outlines Kingfisher's large Golden Triangle land package in British Columbia, where the company is following up a new copper-gold porphyry discovery at Williams and advancing the Hank epithermal system. With about $30 million in the bank, Kingfisher plans roughly 15,000 meters of drilling, plus regional geophysics across its district-scale holdings. Perry says the goal is to prove scale, continuity, and higher-grade zones. Kingfisher trades on the TSX-V under KFR. 

MSD's Ian Wagner speaks with Sean Howarth of Excellon Resources at Deutsche Goldmesse in Frankfurt. Howarth outlines Excellon's renewed focus on Peru, where the company is advancing the past-producing Mallay silver mine toward restart while drilling to extend resources and test parallel zones. He also discusses the nearby Tres Cerros target, an undrilled gold-silver opportunity, along with Excellon's Kilgore gold project in Idaho and German silver assets. The strategy centers on near-term cash flow, resource growth, and silver leverage. Excellon trades on the TSX-V under EXN. 

Talisker Resources CEO Terry Harbort joins MSD's Ian Wagner discusses the company's updated resource at the Bralorne Gold Project in British Columbia, which now totals nearly 3.4 million ounces across measured, indicated, and inferred categories. The update more than doubles the global resource and highlights high-grade material at Mustang and Olympus. Talisker is also advancing a 105,000-meter drill program focused largely on resource conversion, while ramping production at Mustang. Ore sorting, expanded trucking rates, and a coming PEA are key milestones for 2026.

The chaos starts EARLY on this daily comedy show when Rafe wakes up convinced the evil clown from Poltergeist finally came for him… only to discover his blind dog Bo trapped underneath the bed like a furry little cryptid with no exit strategy. Naturally, instead of calmly handling the situation like adults, the show spirals immediately into discussions about utility companies rescuing animals, tow truck conspiracies, and whether MSD has a secret deer extraction task force. You know… journalism.Then the crew dives headfirst into the truly important national debate: what is ACTUALLY the best day of a three-day weekend? Is it the first Saturday because there are “no consequences”? Is Sunday secretly elite because Monday still exists? Or is Monday only enjoyable if you're some kind of psychopath who enjoys thinking about Tuesday? The answers get oddly passionate for a group of people operating on gas station coffee and sarcasm.Meanwhile, competitive eating legend Joey Chestnut returns to the spotlight with legal drama attached to his mustard belt. Joey apparently pleaded guilty to slapping a guy during a bar altercation, which somehow becomes less shocking once the crew starts imagining him assaulting someone with a hot dog. The gang also reacts to Joey setting a NEW world record by consuming 16 pounds of bologna in eight minutes — which is either athletic greatness or a cry for help. Maybe both.The episode somehow gets even weirder with conversations about AI juries replacing humans, Britney Spears offering cops homemade lasagna during a DUI stop, wisdom teeth horror stories, nitrous gas adventures, and King Scott accidentally discovering that tow truck companies can basically repossess your soul after 45 days. Honestly, if anxiety had a group project, it would sound exactly like this episode.Also included:Blind dog rescue operations at 1:30amWhy no one trusts AI to judge crimesThe economics of pontoon weekendsWhy Brittany Spears' lasagna probably crunchesTow truck companies apparently becoming landlords nowWisdom tooth extraction traumaAnalog people vs AI peopleWet t-shirt contest discussions because this is still radio somehowThis daily comedy show delivers peak Rizzuto Show energy: chaotic conversations, sarcastic takes, wildly unnecessary debates, and the kind of ridiculous storytelling that makes you feel better about your own life choices.And yes… somebody absolutely says “Department of Ho Land Security.”Because of course they do.Follow The Rizzuto Show → linktr.ee/rizzshow for more from your favorite daily comedy show.Connect with The Rizzuto Show Comedy Podcast online → 1057thepoint.com/RizzShowHear The Rizz Show daily on the radio at 105.7 The Point | Hubbard Radio in St. Louis, MO.Michigan tenant who called landlord to work on home catches him on camera having sex insideAlachua County woman accused of throwing feces at father during fightJoey Chestnut pleads guilty after bar fight — here's what it will mean for July 4 Nathan's competitionBritney Spears Spoke ‘Nonsensically' During D.U.I. Arrest, Records SaySchlitz beer stops brewing after historic 175-year run in MilwaukeeFriday FailsMasked NJ suspect charged with using fuel, fireworks in Walmart kids section as cover for massive jewelry heistNew York man arrested for driving drunk to pick up friend after DWI arrest: sheriffFlorida woman arrested after golf course joyride fueled by 21(!) mini bottles of FireballIndiana man seen dancing in roadway while cradling rare turtle arrested for meth possessionIt's sugar: Florida man blows fentanyl in deputy's face, sheriff's office saysWoman arrested after Hillsborough Co. deputies chase stolen Red Bull truck across multiple countiesThree Ardmore men arrested, accused of stealing bongs in gas station burglaryMan booked after allegedly stealing ‘O' from Tacoma Police sign, damaging front gateWoman Charged With Smuggling After Shoving Wine Bottle in Her ‘Body Cavity'See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hayasa Metals CEO Joel Sutherland joins MSD's Ian Wagner in Frankfurt to discuss the company's gold and copper exploration strategy in Armenia. Sutherland outlines the broader Armenia thesis, pointing to underexplored geology in the Tethyan Belt, improving Western engagement, and growing interest in critical minerals. He also discusses Hayasa's partnership with Teck at the Vardenis copper-molybdenum project, ongoing work at Urasar, and plans to add three new properties this year. Hayasa trades on the TSX-V under HAY and Frankfurt under FR20. 

Amarc Resources CEO Dr. Diane Nicolson joins MSD's Ian Wagner in Frankfurt to discuss the company's three copper-gold porphyry districts in British Columbia: Joy, Duke, and Ike. Nicolson highlights the Aurora discovery at Joy, describing it as a near-surface, high-grade gold-enriched copper porphyry that could help unlock the broader district. She also discusses Freeport's continued funding at Joy, Boliden's partnership at Duke, and the company's broader strategy as a discoverer, developer, and transactor of major copper-gold systems.

Sirios Resources CEO Jean-Félix Lepage joins MSD's Ian Wagner in Frankfurt to discuss the Cheechoo gold project in Quebec's James Bay region. Lepage outlines the project's nearly three-million-ounce resource, including an open-pit component grading above one gram per tonne with a low strip ratio. He also discusses the company's recent financing, a planned 25,000-meter summer drill program, a resource update expected before year-end, and a PEA targeted for the first half of next year. Sirios trades on the TSX-V under SOI. 

Melanoma, câncer de pulmão, esôfago, mama triplo negativo e colo do útero devem ser as primeiras doenças beneficiadas com o uso de imunoterapia no SUS. A informação foi dada por Rodrigo Cruz, Diretor de Relações Institucionais da MSD, farmacêutica que assinou um termo para a transferência de tecnologia com o governo federal.Nesse episódio do podcast de Biotech and Health, Camila Pepe e Carolina Abelin conversam com o executivo sobre os detalhes do acordo, os prazos e as vantagens da imunoterapia. O diferencial desse tipo de tratamento é que, ao contrário da quimioterapia tradicional, ele é capaz de estimular o próprio sistema de defesa do organismo para combater as células cancerígenas.

Today's episode of The Rizzuto Show turns into a full-on wilderness survival documentary… except nobody survives with dignity intact.The gang kicks things off talking about King Scott's rain-soaked blood drive experience, complete with lightning, wet parking lots, and accusations that his blood immediately got thrown in the trash because “ginger blood isn't FDA approved.” Real teamwork stuff. Then things somehow pivot into a full review of the St. Louis Aquarium, where Rafe realizes he's accidentally been recommending what may actually be a third-grade field trip destination to every adult tourist he's met for the last five years.Apparently, for the low low price of fifty bucks, you too can enjoy seven mirrors, stressed-out otters doing all the heavy lifting, and a ropes course so terrifying it nearly destroyed an entire family emotionally in real time. Nothing says “fun day in St. Louis” like watching a dad's cargo shorts lose a battle against gravity while suspended from the rafters of Union Station.But the true centerpiece of this daily comedy show is Riz's attempted baby deer rescue.A tiny fawn gets trapped inside an MSD fenced enclosure behind his house during a storm, and what begins as a heroic wildlife rescue instantly devolves into one of the funniest group-chat pile-ons in show history. Riz insists he “did everything he could,” while everyone else points out that his version of heroism mostly involved making phone calls, avoiding mud, refusing to climb a fence, and eventually taking a nap while the deer repeatedly knocked itself unconscious.Meanwhile, Moon keeps demanding bolt cutters, Lern is ready to climb barbed wire with a quilt like it's 1987, and Rafe essentially puts Riz on trial for crimes against masculinity. Somehow, despite all odds, the deer survives thanks to the ACTUAL heroes: two MSD workers who show up with keys while Riz continues defending his life choices from the warmth of indoors.Also in this episode:Why St. Louis weather feels personally offensive nowThe aquarium train ride narrated by a wildly underutilized John GoodmanWhy ropes courses are apparently medieval torture devicesThe ethics of touching wild animalsFinal week of school energyAnother kid crawling into a claw machineWhy everyone immediately turned on Riz in the group chatAnd the growing realization that “calling someone else” may actually be Riz's superpowerThis daily comedy show somehow combines wildlife rescue failure, aquarium disappointment, family trauma, weather rage, and public humiliation into one beautifully chaotic morning.Honestly? The baby deer may recover faster than Riz's reputation.Follow The Rizzuto Show → linktr.ee/rizzshow for more from your favorite daily comedy show.Connect with The Rizzuto Show Comedy Podcast online → 1057thepoint.com/RizzShow.Hear The Rizz Show daily on the radio at 105.7 The Point | Hubbard Radio in St. Louis, MO.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Cartier Resources CEO Philippe Cloutier joins MSD's Ian Wagner in Frankfurt to discuss the company's Cadillac gold project in Québec's Abitibi region. Cloutier highlights recent metallurgical test work showing gold recoveries near 97%, improving on historic assumptions and strengthening the case for a new economic assessment. He also discusses Cartier's 3.2-million-ounce resource, a 100,000-meter drill program, new discoveries along the Cadillac trend, and strategic options ranging from toll milling and staged development to joint ventures or M&A along with the company's new U-S listing.

What does truly integrated care look like in practice? Host Matt Crespin captured the conversations at ADHA's first-ever Integrated Care Summit in Broomfield, Colorado this past weekend — bringing together physicians, dentists, periodontists, and public health professionals making the case for breaking down silos. (1:56) Dr. Mychi Nguyen, Chief Medical Officer at Asian Health Services, shares how a patient's powerful words — "How can I be healthy if I don't have teeth?" — launched a dental clinic at her FQHC and explains the AHA's Healthy Smiles, Healthy Hearts initiative transforming dental visits into preventive health opportunities. (8:48) AGD President-elect George J. Schmidt reflects on the growing ADHA-AGD collaboration. (15:19) Dr. Elizabeth Ramos of the American Academy of Periodontology makes the case for hygienists as key communicators of the perio-systemic connection. (24:08) Michael Lazzara, VP of International Business Development of Dento, introduces oral health biomarker testing that gives patients real-time data to motivate behavior change. And (35:37) Holly Kingsbury of the Colorado Community Health Network walks through a promising model for integrating behavioral health screenings into dental visits at FQHCs statewide.Guests: Mychi Nguyen, MD; George J. Schmidt, DMD, FAGD, FICOI; Elizabeth D. Ramos, DDS, MSD, EdD; Michael Lazzara, Dento; Holly Kingsbury, MPHHost: Matt Crespin, MPH, RDH, FADHA

A disability advocate has slammed Louise Upston moving to close the door on treating family carers as state employees. The Disability Issues Minister is introducing a bill to enshrine support services in law. It would reverse a Supreme Court finding they were employed by the Government - and instead give carers support packages. Advocate Jane Carrigan says there are isolated families with little control over their children. She says flinging money at them isn't the answer. She explained people need more support and to be treated as more than an employee of MSD - but for the past 30 years, they've been completely shafted by the system. LISTEN ABOVESee omnystudio.com/listener for privacy information.

What does it take to build the data systems that sit behind your genetic evaluations?This week on the podcast, Ferg catches up with Dan Garrick from Helical. Dan grew up on a sheep, beef and venison farm in the Manawatu before moving to the US at 13, where he went on to complete a PhD in aerospace engineering at Iowa State University. He's the son of Professor Dorian Garrick, one of New Zealand's most respected animal breeding geneticists, and his grandfather was one of the world's leading experts on sharks, making Dan a third-generation PhD.Dan explains how the same maths used to model fluid dynamics around rockets is used to generate breeding values, and how he ended up joining the family business in 2017 to help roll out some of the first production single step evaluations in the US for American Hereford and IGS. That work quickly revealed a major bottleneck in managing the genomic data flowing in from DNA testing labs. That's where Helical was born.Ferg and Dan talk through how Helical now serves breed societies, genetics companies, universities and labs across beef, dairy, sheep, horses, dogs, aquaculture and forestry. They also look ahead at where things are going. From decision support tools and AI in commercial herds, to the potential for wearable devices like virtual fencing collars to generate entirely new breeding values nobody has thought of yet - both Dan and Ferg agree the future is bright for Agriculture. Head Shepherd is brought to you by neXtgen Agri International Limited. We help livestock farmers get the most out of the genetics they farm with. Get in touch with us if you would like to hear more about how we can help you do what you do best: info@nextgenagri.com.Thanks to our sponsors at MSD Animal Health and Allflex, Heiniger Australia and New Zealand, and ProWay Livestock Equipment. Please consider them when making product choices, as they are instrumental in enabling us to bring you this podcast each week.Check out the MSD range HERECheck out Allflex products HERECheck out Heiniger's product range HERECheck out ProWay's product range HERE

This episode covers: Cardiology This Week: A concise summary of recent studies Biomarkers in heart failure Digoxin in HFrEF Scientific Highlights from Heart Failure 2026 Host: Wilfried Mullens Guests: Lynne Stevenson, Dirk van Veldhuisen, Theresa McDonagh Want to watch that episode? Go to: https://esc365.escardio.org/event/2565 Disclaimer: ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. A ny views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own. Declarations of interests: Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel, Dirk van Veldhuisen and Lynne Warner Stevenson have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report:Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi.  Theresa McDonagh has declared to have potential conflicts of interest to report: honoraria from Boeringer Ingelheim. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Bonterra Resources Chairman Cesar Gonzalez joins MSD's Ian Wagner to discuss a busy period for the Abitibi gold developer, including Marc-Andre Pelletier's departure as CEO and Gonzalez stepping in as interim CEO. Gonzalez reviews progress on the Gold Fields joint venture at Barry, where deep drilling has wrapped up and assay results are being prepared. He also outlines work on a Barry PEA and a 10,000-to-12,000-meter drill program at the company's 100%-owned Bachelor-Moroy and Desmaraisville assets, where Bonterra is testing regional and deep feeder-zone targets.

MSD's Ian Wagner reconnects with Blue Moon Metals CEO Christian Kargl-Simard to discuss the company's rapid evolution following a C$156 million financing. Kargl-Simard outlines how Blue Moon plans to fund and sequence multiple assets, including the Nussir copper project in Norway, the Springer tungsten restart in Nevada, and the Blue Moon zinc project in California. He also discusses potential strategic capital for tungsten and APT production, growing U.S. investor interest, and the optionality at Apex for direct-shipping germanium and gallium ore.

Jane Kellock joins Mark to talk through the production and business decisions that have shaped their Merino operation in South Australia's Mid North. From running a non-mulesed flock for more than 20 years to building a breeding programme focused on lamb survival, Jane explains how genetics, condition scoring and lessons learned from attending previous LambEx conferences have helped their business through some brutal seasons.Jane also discusses the importance of making strategic decisions before drought hits, why mixed farming regions risk losing livestock knowledge, and what producers can expect from LambEx26.Tickets available here: https://www.lambex.org.au/ticketsEarlybird tickets finish Friday, the 15th of May. Head Shepherd is brought to you by neXtgen Agri International Limited. We help livestock farmers get the most out of the genetics they farm with. Get in touch with us if you would like to hear more about how we can help you do what you do best: info@nextgenagri.com.Thanks to our sponsors at MSD Animal Health and Allflex, Heiniger Australia and New Zealand, and ProWay Livestock Equipment. Please consider them when making product choices, as they are instrumental in enabling us to bring you this podcast each week.Check out the MSD range HERECheck out Allflex products HERECheck out Heiniger's product range HERECheck out ProWay's product range HERE

Scorpio Gold CEO Zayn Kalyan joins MSD's Ian Wagner to discuss new drill results from the Manhattan Gold District in Nevada, including a standout intercept from the Zanzibar Trend grading 10.4 grams per tonne gold over 5.7 meters, with an uncapped interval that would calculate above 43 grams. Kalyan explains how Zanzibar could add near-surface ounces beside the existing resource pit, while drilling continues at Black Mammoth, Gold Wedge Deep, and the Gap Zone. Scorpio is also advancing toward a potential NASDAQ listing.

Great Pacific Gold CEO Greg McCunn joins MSD's Ian Wagner to discuss new drilling at the Kavasuki target within the Wild Dog project in Papua New Guinea. McCunn explains how Kavasuki may represent a third high-grade shoot along the broader Wild Dog structural corridor, with drilling showing broad near-surface mineralization and a low-grade halo around higher-grade veining. The company is now testing below a fault with hole seven, while planning step-outs and weighing a broader 18-month drill strategy backed by roughly C$26 million in treasury.

MSD's Ian Wagner speaks with Precipitate Gold CEO Jeff Wilson about the company's current drill program at Pueblo Grande in the Dominican Republic, located beside Barrick's Pueblo Viejo mine. Wilson explains how a previously undrilled IP chargeability anomaly emerged after Barrick returned the project, and why drilling through a hard lithocap could test for gold and copper mineralization beneath. The conversation also covers planned drilling at the flagship Juan de Herrera project, including Ginger Ridge, GoldQuest's nearby discoveries, Dominican exploration rules, and Precipitate's recent share price move.

MSD's Ian Wagner speaks with Atlas Salt CEO Nolan Peterson about financing progress at the Great Atlantic Salt Project in Newfoundland. Peterson says the company has now gone to market with due diligence materials for prospective lenders, targeting a capital stack led by senior secured debt, equipment financing, and potential government support. The discussion covers offtake talks, recent salt price strength, the project's stable cash-flow profile, and why Peterson believes Atlas should be valued more like infrastructure than a traditional junior miner. 

Matt Hood on farm succession, agribusiness banking, and building better farm businesses.Based in Marlborough, Matt has worked across sheep and beef, dairy, and viticulture businesses in both New Zealand and Australia, with a focus on succession planning, equity partnerships, and helping farm businesses make better decisions around people, capital, and structure.Matt explains where he sees the gap between being good on the tools and being good in business. As businesses grow, priorities shift to managing people, finances, and decision-making, and that is often where performance stalls, especially during succession. On that note, succession is a major passion for Matt. Not just how to transfer assets, but how to run the process properly by having early conversations and making sure there is actually a business worth passing on, alongside a strong emphasis on purpose, both for the next generation coming in and for those stepping back.Matt also explains what the good, strong businesses he's come across consistently do well. It usually comes down to a good understanding of numbers, avoiding surprises, and keeping emotion out of decision-making.Matt and Mark also discuss what "good" looks like from a banking perspective and how to build up a good relationship with your bank so that you can work together for the success of everyone. This is an hour every farmer needs to listen to. Head Shepherd is brought to you by neXtgen Agri International Limited. We help livestock farmers get the most out of the genetics they farm with. Get in touch with us if you would like to hear more about how we can help you do what you do best: info@nextgenagri.com.Thanks to our sponsors at MSD Animal Health and Allflex, Heiniger Australia and New Zealand, and ProWay Livestock Equipment. Please consider them when making product choices, as they are instrumental in enabling us to bring you this podcast each week.Check out the MSD range HERECheck out Allflex products HERECheck out Heiniger's product range HERECheck out ProWay's product range HERE

Kootenay Silver CEO Jim McDonald joins MSD's Ian Wagner to outline the company's shift toward development following the major silver price breakout. The company is advancing its La Cigarra project toward a near-term PEA, which could re-rate the business from explorer to developer. Meanwhile, aggressive drilling at the high-grade Columba discovery aims to grow the resource toward the key 100 million ounce threshold. With over $30 million in treasury and multiple projects in Mexico, Kootenay is positioning for long-term production growth, potential revaluation, and increased strategic interest from larger mining companies.

Yukon Metals is expanding its district-scale copper-gold exploration strategy in the Yukon with the addition of the Sumo property, located near its flagship Birch project. The company sees strong porphyry potential supported by historical drilling and favorable infrastructure access. Exploration this season will integrate Sumo alongside ongoing work at Birch and the AZ target, where geophysics and drilling are set to begin in mid-May. CEO Jim Coates spoke with MSD's Ian Wagner and emphasized a tightening global copper supply backdrop and sees Yukon Metals positioning itself for discovery-driven catalysts, with geophysical results and initial drill visuals expected by mid-summer.

This episode covers: Cardiology This Week: A concise summary of recent studies Genetics and genetic testing in HCM Asymptomatic aortic valve stenosis Statistics Made Easy: Mediation analysis Host: Wilfried Mullens Guests: JP Carpenter, Caroline Coats, Marc Dweck Want to watch that episode? Go to: https://esc365.escardio.org/event/2564 Want to watch that extended interview on asymptomatic aortic valve stenosis, go to: https://esc365.escardio.org/event/2564?resource=interview   Disclaimer  ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails.  ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.    Declarations of interests Stephan Achenbach, Yasmina Bououdina, Antonio Greco and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. Caroline Coats has declared to have potential conflicts of interest to report: in the last 5 years, consultant/advisor to Bayer, Bristol Myers Squibb, Cytokinetics, Sanofi, Roche Diagnostics. Marc Dweck has declared to have potential conflicts of interest to report: consultancy fees from Novartis, Silence, and AstraZeneca related to aortic stenosis and development of a medical therapy. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Wilfried Mullens Guest: Marc Dweck Want to watch that extended interview on https://esc365.escardio.org/event/2564?resource=interview Go to: Want to watch that episode? Go to: https://esc365.escardio.org/event/2564   Disclaimer ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina, Antonio Greco and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. Marc Dweck has declared to have potential conflicts of interest to report: consultancy fees from Novartis, Silence, and AstraZeneca related to aortic stenosis and development of a medical therapy. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

MSD's Ian Wagner speaks with Defense Metals CEO Mark Tory about advancing the Wicheeda rare earth project in British Columbia. The company's pre-feasibility study outlines production of roughly 5,000 tonnes of NdPr annually, supported by strong economics and a potential 60-40 debt-equity financing structure, including interest from Export Development Canada. Tory highlights China's dominance in rare earths and how Western governments are working to establish secure supply chains, including pricing floors. With permitting underway and a feasibility study planned, upcoming catalysts include strategic partnerships and potential government-backed funding initiatives.

Send us Fan MailIs the era of just managing Parkinson's symptoms finally coming to an end?In this clip from our episode “How AI Is Helping The Fight Against Parkinson's”, host David E. Williams and guest Gene Mack, CEO of Gain Therapeutics, share why the early signals from their lead drug candidate are too compelling to ignore.Listen to the full episode here

Stefan Sklepowicz of Kirkland Lake Discoveries joins the MSD pod to discuss the recent drill results from the past-producing Mirado property in Ontario's Abitibi jurisdiction. The company recently published a highlight hole of 121m of 1.01 g/t Au in a 75m step-out hole, which caught the market's attention. Stefan discusses the geological dynamics of this hole and its other pending holes coming down the pipeline.

Tudor Gold CEO Joe Ovsenek speaks with MSD's Ian Wagner, outlining steady progress at Treaty Creek, where a PEA is targeting a roughly 10,000-tonne-per-day underground operation producing up to 300,000 ounces annually. Metallurgical testing is nearing completion, while drilling at Perfect Storm and CBS aims to unlock additional multi-million-ounce deposits. The company also provided clarity on the Seabridge tunnel situation following a regulatory pause on permitting.

You'd never ignore your interest rate, so why aren't you tracking your genetic gain? This week, Ferg catches up with Chad Taylor for an update on what has been happening at Mumblebone and the recent work around footrot and feet structure they have been involved with as part of the 'Genetics of foot health in Merinos' project.Ferg and Chad also discuss genetic gain at Mumblebone and how it is being pushed in practical terms. For example they are using ram lambs more heavily, joining ewe lambs, using genomics and utilising custom indexes in selection decisions. Chad also explains why genetic gain should be tracked and questioned just as closely as interest rates, because both compound over time and have a direct impact on the long-term performance of the business.Finally, Ferg and Chad discuss what supports all the progress they're making on-farm. Chad is very keen on building the right team and aligning people with the direction of the business, and he shares the impact of bringing staff into the bigger picture by "opening the books" so they know how the business operates financially.It's always a pleasure to have Chad on the podcast. Tune in to hear a top operator's approach to breeding great sheep. Links:Precision Sheep HQ: https://www.precisionsheephq.com/feed'Genetics of foot health in Merinos' project cull ram challenge: Email amy@nextgenagri.comMineral basics for healthier stock and higher returns: https://thehub.nextgenagri.com/c/events/mineral-basics-for-healthier-stock-and-higher-returnsHead Shepherd is brought to you by neXtgen Agri International Limited. We help livestock farmers get the most out of the genetics they farm with. Get in touch with us if you would like to hear more about how we can help you do what you do best: info@nextgenagri.com.Thanks to our sponsors at MSD Animal Health and Allflex, Heiniger Australia and New Zealand, and ProWay Livestock Equipment. Please consider them when making product choices, as they are instrumental in enabling us to bring you this podcast each week.Check out the MSD range HERECheck out Allflex products HERECheck out Heiniger's product range HERECheck out ProWay's product range HERE

Send us Fan MailFor decades, Parkinson's patients have been offered only symptom management. No drug has ever slowed the disease itself. A small clinical stage biotech may be about to change that.Gene Mack, CEO, Gain Therapeutics joins host David E. Williams to discuss the science behind a potential first disease modifying therapy for Parkinson's, how AI is accelerating drug discovery, and what it takes to build a biotech in one of the toughest capital markets in years.

MSD's Trevor Hall travelled to the Sudbury Basin this week with the team from Magna Mining. This interview with CEO Jason Jessup, took place following an underground visit to the McCreedy West Mine on Tuesday and prior to a visit to the Levack Mine, currently in development, on Wednesday. Jason and Trevor discuss the importance of McCreedy crashflow as the company continues to progress Levack towards a new PEA and restart decision. The conversation also focuses on the culture of Magna within the basin and their unique approach to exploration and resource development.

MSD's Ian Wagner speaks with Talisker Resources CEO Terry Harbort on standout face samples from the Mustang Mine, including bonanza-grade hits along the BK vein. The company is accelerating development while expanding its drill program to over 100,000 meters, targeting resource growth, conversion, and potential new mines across its broader Bralorne district.

João Canêdo of Fenix Gold, own and operated by Rio2, joins Trevor for an MSD interview following last week's site visit to the Fenix Gold Project. João provides a thorough update on the mine's construction, which is close to complete. The company has produced dore leading up to its full commissioning. But Fenix continues to think long-term with the strategy of a Phase II. He walks us through those ideas of how to truly optimize the mine plan.

This week, Mark catches up with Will Barton from Gundagai Meat Processors (GMP) to chat about what has changed since his last appearance on the podcast and where things are heading next for Gundagai.Gundagai has built a reputation for doing things differently, with a clear focus on eating quality and how that is measured and paid for. Will explains how a focus on eating quality, particularly intramuscular fat, has shaped their grid, and why balancing that with lean meat yield and animal health has been critical to maintaining consistency. Will also explains their feedback loop between processor and producer. With full EID integration now in place, the ability to link on farm decisions directly to carcass outcomes is no longer theoretical and is now happening at scale. Head Shepherd is brought to you by neXtgen Agri International Limited. We help livestock farmers get the most out of the genetics they farm with. Get in touch with us if you would like to hear more about how we can help you do what you do best: info@nextgenagri.com.Thanks to our sponsors at MSD Animal Health and Allflex, Heiniger Australia and New Zealand, and ProWay Livestock Equipment. Please consider them when making product choices, as they are instrumental in enabling us to bring you this podcast each week.Check out the MSD range HERECheck out Allflex products HERECheck out Heiniger's product range HERECheck out ProWay's product range HERE

This episode covers: Cardiology This Week: A concise summary of recent studies Time for physiological pacing in heart failure? Same-day discharge after EP procedures: from evidence to practice EHRA 2026 Scientific Highlights Host: Gerd Hindricks Guests: Haran Burri, Emma Svennberg, Julia Vogler Want to watch that episode? Go to: https://esc365.escardio.org/event/2555    Disclaimer ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video.  The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own.   Declarations of interests Stephan Achenbach, Yasmina Bououdina and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Haran Burri has declared to have potential conflicts of interest to report: institutional research and fellowship support or speaker honoraria from Abbott, Biotronik, Boston Scientific, Medtronic, Microport. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honorary from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Gerd Hindricks has declared to have potential conflicts of interest to report: institutional research and fellowship support or speaker honoraria from Abbott, Biotronik, Boston Scientific, Medtronic, Microport. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Helmut Puererfellner has declared to have potential conflicts of interest to report: speaker fees, honoraria, consultancy, advisory board fees, investigator, committee member, etc., including travel funding related to these activities for the following companies: Abbott, Biotronik, Biosense Webster, Boston Scientific, Daiichi Sankyo, Medtronic. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson. Julia Vogler has declared to have potential conflicts of interest to report: honoraria for talks: Abbott.

Talisker Resources is pushing aggressively into growth mode, expanding its 2026 drill program from 30,000 to 100,000 meters while advancing development at the Bralorne Gold Camp in British Columbia. MSD's Ian Wagner talks with CEO Terry Harbort, who outlines strong early drill results from the Bralorne West area, alongside a $52 million financing to accelerate exploration across Mustang, Olympus, and Congress. With a resource update expected in May and production already underway, Talisker is positioning itself to transition from small-scale producer to a multi-asset, district-scale gold operation.

Rick Van Niewenhuyse, CEO, and Shawn Khunkhun, President, of Contango Silver and Gold join MSD to discuss the now closed merger between their respected two companies (Contango ORE and Dolly Varden). The two talk about the symmetries the combination provides shareholders, balancing production expectations with exploration capital, and what the execution process needs to reveal over the next few years.

Yesterday, Apex Critical Metals published their first drill results from the Rift Rare Earth Project in Nebraska. Hole 2 returned 81.6 m at 2.02% REO, including 50.9 m at 2.40% REO. The results also returned a highly enriched Neodymium-Praseodymium ("NdPr") zone with an average NdPr distribution of 49% over 10 m with an average 0.75% REO grade. Joness Lang of Apex talks about the results in this episode of MSD.

MSD's Ian Wagner speaks with Bonterra Resources CEO Marc-André Pelletier about a new resource update at the Bachelor and Moroy deposits, adding roughly 100,000 ounces in the measured and indicated categories. The update builds on earlier growth across the portfolio, including a 600,000 ounce increase at the company's JV with Goldfields. Bonterra also plans additional drilling at Bachelor and eyes upcoming assay results from it's exploration joint venture with Gold Fields, alongside ongoing technical studies and development evaluation work on the company's projects.

MSD's Ian Wagner speaks with Scorpio Gold CEO Zayn Kalyan about new drill results from the Manhattan District, highlighting a key step-out at the Black Mammoth target. Early drilling confirms broad mineralization outside the current resource, supporting potential district-scale growth. With multiple rigs turning across Black Mammoth, Zanzibar, and core zones, Scorpio continues advancing toward its 2-million-ounce goal while maintaining a steady flow of results to market.

Great Pacific Gold is accelerating exploration at its Wild Dog Project in Papua New Guinea, with two drill rigs active across multiple targets. MSD's Ian Wagner spoke with CEO Greg McCunn to discuss ongoing drilling at Kavasuki, where results continue to show broad, near-surface gold mineralization, and early-stage work at Kasie Ridge targeting deeper porphyry potential. The company also announced an upsized $20 million financing, positioning it to expand drilling and advance priority targets through 2026.

Francis Macdonald of Li-FT Power joins MSD for a thorough update on all of the company's recent news, including its closing of a 75% in the Galinée property, and update on the merger with Winsome Resources, and the scoping study for a Lithium Carbonate Converter at the Yellowknife Project.